Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 8/20 | 0.72 |
| ▸ | MAPT | P10636 | 8/20 | 0.72 |
| ▸ | TP53 | P04637 | 6/20 | 0.72 |
| ▸ | RECQL | P46063 | 6/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.72 |
| ▸ | LMNA | P02545 | 5/20 | 0.72 |
| ▸ | HPGD | P15428 | 5/20 | 0.72 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.72 |
| ▸ | APP | P05067 | 4/20 | 0.72 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 0.72 |
| ▸ | SLCO2B1 | O94956 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29826664 | 1.00 | MEN1 (0.72) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL31326068 | 1.00 | MEN1 (0.72) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL12639983 | 0.88 | MEN1 (0.74) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Quercetin SCHEMBL729498 | 0.86 | MEN1 (0.76) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL22625755 | 0.85 | MEN1 (0.61) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL10335363 | 0.84 | MEN1 (0.79) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL4879748 | 0.84 | AMY1A (0.78) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL7660030 | 0.84 | NOX4 (0.76) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL14764339 | 0.84 | MEN1 (0.76) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| SCHEMBL14764381 | 0.84 | CYP1A1 (0.76) | MEN1KMT2AKDM4ECYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023130141-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING PHYSIOLOGICAL HEALTH DEFENSES | QUINTESSENTIALI, LLC (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023102111-A1 | SMALL MOLECULE INHIBITORS OF REPEAT ASSOCIATED NON-AUG (RAN) TRANSLATION AND COMBINATION THERAPIES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023065376-A1 | USE OF COMPOSITION COMPRISING ASTILBIN AND/OR ISOMER THEREOF IN PREPARATION OF DRUG FOR TREATING PSORIASIS | 广州白云山敬修堂药业股份有限公司 | 2023-04-27 | — | — | WO | disclosed |
| US-20230053152-A1 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | BENOBIO CO., LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-3004336-B1 | ENZYMES CATALYZING THE GLYCOSYLATION OF POLYPHENOLS | UNIVERSITÄT HAMBURG (DE) | 2017-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053152-A1 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | BET1, BRD4, BRD3 | MEN1 4278/4885KMT2A 884/4885KDM4E 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.